Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Nonobstructive CAD: Recognition needed, treatment options sought Erik Swain
-
- FDA approves left atrial appendage closure device
- FDA requires labeling changes for testosterone therapies to reflect CV risk
- Advanced age, comorbidities may weaken ICD survival benefit
- Circulating neprilysin may predict CV death, HF hospitalization
- Concomitant NSAIDs with antithrombotic therapy after MI worsen outcomes
- Frequent sauna use associated with reduced risk for CV-related, all-cause mortality in men
- Low systolic BP, multiple BP medications increase mortality risk in frail elderly adults
- Many with AF qualify for oral anticoagulation therapy under new guidelines
-
- Musculoskeletal pain common among health care workers participating in interventional procedures
- Patients with high genetic risk for CHD benefit most from statin therapy
- Stress could be factor for poor MI recovery in young women
- New recommendations for managing high BP anticipated in 2016
- Nathaniel Reichek, MD: A pioneer in the development of cardiac MRI
- Medical advice motivates patients to reduce sodium intake
- Automated text messaging may improve CV medication adherence
- CADISS: No difference in treatment with antiplatelets, anticoagulants after cervical artery dissection
-
- Early-onset vasomotor symptoms linked with endothelial dysfunction
- Infants with certain congenital defects, genetic variant show better postsurgical outcomes
- LEGACY: Weight loss improves AF burden
- Monthly alirocumab may provide additional treatment option for lowering LDL
- OSLER: Two studies indicate long-term safety, efficacy of evolocumab for LDL reduction
- PARTNER 1: TAVR equivalent to surgery in high-risk patients, better than standard care in inoperable patients
- PEGASUS–TIMI 54: Ticagrelor linked with better outcomes in patients at least 1 year after MI
- Plant-based diet lowers risk for CVD mortality
-
- Practice changes can reduce radiation exposure in pediatric cardiac cath lab
- PROMISE: CTA, functional testing associated with similar outcomes in patients with suspected CAD
- SCOT-HEART: CTCA may reduce future MI risk in patients with suspected angina
- Stentless bioprosthetic valve effective for patients with congenital heart disease
- Third-generation balloon-expandable TAVR system linked to lower death, stroke rates
- TOTAL: Manual thrombectomy with PCI does not improve outcomes, increases short-term stroke rate
- Vasoactive-ventilation-renal score predicts outcomes after pediatric cardiac surgery
- The role of lipid-lowering therapies: A look at the guidelines Alexander Kantorovich, PharmD, BCPS; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
-
- Trial Scorecard: CLEVER
- Trial Scorecard: CREDO-Kyoto
- Trial Scorecard: LEGACY
- Trial Scorecard: PARTAGE
- Trial Scorecard: PEGASUS-TIMI 54
- Trial Scorecard: PRO VA
- Trial Scorecard: PROMISE
- Trial Scorecard: SCOT-HEART
-
- Trial Scorecard: TOTAL